R Squared’s LifeMD LFMD Stock Holding History

R Squared’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,367	Closed	-$41K	–	625
2026 Q1	$41K	Buy	+11,367	New	+$39.3K	0.02%	430
2025 Q1	–	Sell	-430	Closed	-$2.13K	–	943
2024 Q4	$2.13K	Buy	+430	New	+$2.25K	﹤0.01%	1459

Other funds holding LFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

R Squared's LFMD Position: Q2 2026 in Review

R Squared sold out of LifeMD (LFMD) in Q2 2026, closing a stake of 11,367 shares — an estimated $41K sold.

R Squared first reported a position in LFMD in Q4 2024 and held it in 2 quarters. The position peaked at $41K in Q1 2026. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

R Squared reported no remaining LifeMD position as of Q2 2026 after selling out during the quarter.
R Squared sold 11,367 LifeMD shares in Q2 2026, an estimated $41K.
R Squared first reported a position in LifeMD in Q4 2024 and held it in 2 quarters.
R Squared's LifeMD position peaked at $41K in Q1 2026.
116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.